ATRC | AtriCureNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$60.41
+$0.53 (+0.89%)

AtriCure (ATRC) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $60.41 vs 50 $56.03 / 200 $38.28
Projection
No cross projected
Test
No active test
Last cross
Golden cross 13 Aug 2026 ยท projected 22 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $61.25 vs 50 $38.41 / 200 $36.14
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Golden cross week of 21 Sep 2026 ยท projected 27 bars out

4-hour as of 3 Nov 13:30 ET

Price
above both $60.42 vs 50 $57.54 / 200 $45.90
Projection
No cross projected
Test
No active test
Last cross
Golden cross 10 Jul 2026 ยท projected 17 bars out

Cross history

30
crosses on record since 2017
15 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
week of 21 Sep 2026Golden moderateweekly27 bars outActive Cross Test
13 Aug 2026Golden steepdaily22 bars outNot tested
10 Jul 2026Golden4-hour17 bars outNot tested
17 Mar 2026Death steepdaily30 bars outNot tested
18 Feb 2026Death4-hour13 bars outNot tested

About ATRC

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$44.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.